Cinclus Pharma Holding AB (OSTO:CINPHA) EPS (Basic) : kr-4.09 (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB EPS (Basic)?

Cinclus Pharma Holding AB's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was kr-0.72. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was kr-4.09.

Cinclus Pharma Holding AB's EPS (Diluted) for the three months ended in Mar. 2025 was kr-0.72. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was kr-4.09.

Cinclus Pharma Holding AB's EPS without NRI for the three months ended in Mar. 2025 was kr-0.72. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -4.09.

During the past 3 years, the average EPS without NRI Growth Rate was -37.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Cinclus Pharma Holding AB's highest 3-Year average EPS without NRI Growth Rate was -37.30% per year. The lowest was -37.30% per year. And the median was -37.30% per year.

Cinclus Pharma Holding AB EPS (Basic) Historical Data

The historical data trend for Cinclus Pharma Holding AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB EPS (Basic) Chart

Cinclus Pharma Holding AB Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

-1.76

-5.76

-4.97

-4.54

Cinclus Pharma Holding AB Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial						-0.79	-1.41	-0.79	-1.17	-0.72

Cinclus Pharma Holding AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Cinclus Pharma Holding AB's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-168.031	-	0)	/	37.048
	=	-4.54

Cinclus Pharma Holding AB's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-33.672	-	0)	/	46.538
	=	-0.72

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-4.09

Cinclus Pharma Holding AB (OSTO:CINPHA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Cinclus Pharma Holding AB EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cinclus Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

J8P:Germany

Address

Kungsbron 1, Stockholm, SWE, SE-111 22

Website

https://www.cincluspharma.com

Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines